• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Decreased plasma protein binding of valproate in patients with acute head trauma.急性颅脑外伤患者丙戊酸盐的血浆蛋白结合率降低。
Br J Clin Pharmacol. 1994 Jun;37(6):559-62. doi: 10.1111/j.1365-2125.1994.tb04304.x.
2
Clinical implications of serum protein binding in epileptic children during sodium valproate maintenance therapy.丙戊酸钠维持治疗期间癫痫患儿血清蛋白结合的临床意义
Ther Drug Monit. 1984;6(4):414-23. doi: 10.1097/00007691-198412000-00006.
3
Valproate Protein Binding Is Highly Variable in ICU Patients and Not Predicted by Total Serum Concentrations: A Case Series and Literature Review.丙戊酸盐蛋白结合在ICU患者中高度可变,且不能由血清总浓度预测:病例系列研究与文献综述
Pharmacotherapy. 2017 Apr;37(4):500-508. doi: 10.1002/phar.1912. Epub 2017 Mar 16.
4
Effect of valproate on free plasma phenytoin concentrations.丙戊酸盐对血浆中游离苯妥英浓度的影响。
Br J Clin Pharmacol. 1984 Jul;18(1):17-20. doi: 10.1111/j.1365-2125.1984.tb05015.x.
5
Unbound phenytoin plasma concentrations in patients comedicated with sodium valproate--the predictive value of plasma albumin concentration.丙戊酸钠合并用药患者的游离苯妥英血浆浓度——血浆白蛋白浓度的预测价值
Br J Clin Pharmacol. 1989 Jun;27(6):843-9. doi: 10.1111/j.1365-2125.1989.tb03448.x.
6
Valproate and palmitate binding to human serum albumin: an hypothesis on obesity.
Mol Pharmacol. 1990 May;37(5):704-9.
7
Valproate and palmitate binding to serum albumin in valproate-treated patients. Relation to obesity.
Epilepsy Res. 1993 Sep;16(1):55-64. doi: 10.1016/0920-1211(93)90040-e.
8
Valproate protein binding following rapid intravenous administration of high doses of valproic acid in patients with epilepsy.癫痫患者快速静脉注射高剂量丙戊酸后丙戊酸盐的蛋白结合情况。
J Clin Pharm Ther. 2007 Aug;32(4):365-71. doi: 10.1111/j.1365-2710.2007.00831.x.
9
Plasma concentrations of unbound valproate and the management of epilepsy.
Aust N Z J Med. 1987 Dec;17(6):574-9. doi: 10.1111/j.1445-5994.1987.tb01259.x.
10
Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy.苯妥英钠与丙戊酸盐的相互作用:癫痫患者唾液监测的重要性。
Br Med J (Clin Res Ed). 1982 Jan 2;284(6308):13-6. doi: 10.1136/bmj.284.6308.13.

引用本文的文献

1
Intranasal delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury: screening based on pharmacological and physiological properties.经鼻腔给予靶向线粒体的神经保护化合物治疗创伤性脑损伤:基于药理学和生理学特性的筛选。
J Transl Med. 2024 Feb 16;22(1):167. doi: 10.1186/s12967-024-04908-2.
2
Effect of Traumatic Brain Injury, Erythropoietin, and Anakinra on Hepatic Metabolizing Enzymes and Transporters in an Experimental Rat Model.创伤性脑损伤、促红细胞生成素和阿那白滞素对实验大鼠模型肝脏代谢酶和转运体的影响
AAPS J. 2015 Sep;17(5):1255-67. doi: 10.1208/s12248-015-9792-y. Epub 2015 Jun 12.
3
Effect of time, injury, age and ethanol on interpatient variability in valproic acid pharmacokinetics after traumatic brain injury.时间、损伤、年龄和乙醇对创伤性脑损伤后丙戊酸药代动力学患者间变异性的影响。
Clin Pharmacokinet. 2007;46(4):307-18. doi: 10.2165/00003088-200746040-00004.
4
Pharmacological prophylaxis of post-traumatic epilepsy.创伤后癫痫的药物预防
Drugs. 2000 May;59(5):1091-9. doi: 10.2165/00003495-200059050-00005.
5
Pharmacokinetic alterations after severe head injury. Clinical relevance.
Clin Pharmacokinet. 1998 Sep;35(3):209-21. doi: 10.2165/00003088-199835030-00004.
6
Increases in metabolism of valproate and excretion of 6beta-hydroxycortisol in patients with traumatic brain injury.创伤性脑损伤患者丙戊酸盐代谢增加及6β-羟基皮质醇排泄增加。
Br J Clin Pharmacol. 1998 Feb;45(2):101-5. doi: 10.1046/j.1365-2125.1998.00652.x.

本文引用的文献

1
Apparent valproic acid neurotoxicity in a hypoalbuminemic patient.
Ann Pharmacother. 1993 Jan;27(1):32-5. doi: 10.1177/106002809302700107.
2
The phenomenon of the acute phase response.急性期反应现象
Ann N Y Acad Sci. 1982;389:39-48. doi: 10.1111/j.1749-6632.1982.tb22124.x.
3
Monitoring of free valproic acid levels?
Ther Drug Monit. 1980;2(2):199-201. doi: 10.1097/00007691-198004000-00015.
4
Systemic interaction between valproic acid and free fatty acids in rhesus monkeys.
Epilepsia. 1982 Dec;23(6):649-56. doi: 10.1111/j.1528-1157.1982.tb05080.x.
5
Protein binding of valproic acid in uremic patients.
Neurology. 1980 May;30(5):557-9. doi: 10.1212/wnl.30.5.557-a.
6
Clinical implications of serum protein binding in epileptic children during sodium valproate maintenance therapy.丙戊酸钠维持治疗期间癫痫患儿血清蛋白结合的临床意义
Ther Drug Monit. 1984;6(4):414-23. doi: 10.1097/00007691-198412000-00006.
7
Pharmacokinetics of valproic acid in the elderly.丙戊酸在老年人中的药代动力学
Br J Clin Pharmacol. 1984 Jun;17(6):665-9. doi: 10.1111/j.1365-2125.1984.tb02401.x.
8
Free level monitoring of antiepileptic drugs. Clinical usefulness and case studies.抗癫痫药物的游离水平监测。临床实用性及病例研究。
Clin Pharmacokinet. 1984 Jan;9 Suppl 1:71-8. doi: 10.2165/00003088-198400091-00009.
9
Importance of unbound phenytoin serum levels in head trauma patients.头部创伤患者中游离苯妥英血清水平的重要性。
J Trauma. 1983 Dec;23(12):1058-60. doi: 10.1097/00005373-198312000-00007.
10
Diurnal fluctuations in free and total plasma concentrations of valproic acid at steady state in epileptic patients.癫痫患者稳态时血浆中游离丙戊酸和总丙戊酸浓度的昼夜波动。
Ther Drug Monit. 1983 Jun;5(2):191-6. doi: 10.1097/00007691-198306000-00007.

急性颅脑外伤患者丙戊酸盐的血浆蛋白结合率降低。

Decreased plasma protein binding of valproate in patients with acute head trauma.

作者信息

Anderson G D, Gidal B E, Hendryx R J, Awan A B, Temkin N R, Wilensky A J, Winn H R

机构信息

Department of Pharmacy, School of Pharmacy, University of Washington, Seattle 98195.

出版信息

Br J Clin Pharmacol. 1994 Jun;37(6):559-62. doi: 10.1111/j.1365-2125.1994.tb04304.x.

DOI:10.1111/j.1365-2125.1994.tb04304.x
PMID:7917774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1364815/
Abstract
  1. One hundred and ten plasma samples were obtained from 50 patients treated with valproate for prophylaxis of post-traumatic head injuries. The samples were selected to include a wide range of albumin concentrations and were assayed for free and total valproate concentrations. Valproate binding parameters were determined from the Scatchard equation for one binding site using reweighted least squares analysis. 2. Plasma albumin concentrations were measured in 130 patients with head trauma. They started to decrease immediately after trauma, reaching a minimum at 5-7 days of approximately 24% of baseline value and did not return to normal until 1 month. 3. The free fraction of valproate varied six to seven-fold as albumin concentration ranged from 1.5 to 4.8 g 100 ml-1 (218-696 mumol l-1). The mean association constant for binding (Ka) was 0.008 mumol l(-1) and the mean number of binding sites (N) was 2.0. There values were similar to those reported for valproate in otherwise healthy patients with epilepsy. 4. Because of saturable protein binding of valproate, hypoalbuminaemia may necessitate the monitoring of free valproate concentrations to avoid toxicity when valproate is used in patients with acute head injury.
摘要
  1. 从50例接受丙戊酸盐预防创伤后脑损伤治疗的患者中获取了110份血浆样本。样本的选择涵盖了广泛的白蛋白浓度范围,并对游离和总丙戊酸盐浓度进行了测定。使用重新加权最小二乘法从单结合位点的Scatchard方程确定丙戊酸盐结合参数。2. 对130例头部创伤患者测量了血浆白蛋白浓度。创伤后白蛋白浓度立即开始下降,在5 - 7天达到最低点,约为基线值的24%,直到1个月才恢复正常。3. 随着白蛋白浓度在1.5至4.8 g/100 ml-1(218 - 696 μmol/l-1)范围内变化,丙戊酸盐的游离分数变化了6至7倍。结合的平均缔合常数(Ka)为0.008 μmol/l-1,平均结合位点数(N)为2.0。这些值与在其他方面健康的癫痫患者中报道的丙戊酸盐的值相似。4. 由于丙戊酸盐存在可饱和的蛋白质结合,当丙戊酸盐用于急性头部损伤患者时,低白蛋白血症可能需要监测游离丙戊酸盐浓度以避免毒性。